S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10

Glanbia (GLB) Share Forecast, Price & News

GBX 11.43
+0.18 (+1.60%)
(As of 05/27/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
5 shs
Average Volume
100,979 shs
Market Capitalization
£31.65 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive GLB News and Ratings via Email

Sign-up to receive the latest news and ratings for Glanbia and its competitors with MarketBeat's FREE daily newsletter.

Glanbia logo

About Glanbia

Glanbia plc operates as a nutrition company worldwide. The company manufactures and sells sports nutrition and lifestyle nutrition products in various formats, including powders, ready-to-eat bars and snacking foods, and ready-to-drink beverages through various channels, such as specialty retail, online, and gyms, as well the food, drug, mass, and club channels. It engages in the manufacture and sale of cheese, dairy, and non-dairy nutritional and functional ingredients, and vitamin and mineral premixes. In addition, the company engages in the financing, research and development, property and land dealing, receivables management, management, property leasing, business service, and weight management solutions businesses. It operates a portfolio of brands, including OPTIMUM NUTRITION, SlimFast, BSN, ISOPURE, NUTRAMINO, think!, Amazing Grass, and BODY&FIT brands. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.


See More Headlines

Industry, Sector and Symbol

Food - Major Diversified
Year Founded

Sales & Book Value

Annual Sales
£4.20 billion
Cash Flow
GBX 81.88 per share
Book Value
GBX 604.10 per share


Pretax Margin




Free Float
Market Cap
£31.65 million
Not Optionable

Company Calendar

Ex-Dividend for 5/6 Dividend
Dividend Payable


Overall MarketRank

1.31 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.3Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Glanbia (LON:GLB) Frequently Asked Questions

How often does Glanbia pay dividends? What is the dividend yield for Glanbia?

Glanbia declared a dividend on Thursday, March 3rd. Stockholders of record on Thursday, March 24th will be given a dividend of GBX 0.18 per share on Friday, May 6th. This represents a dividend yield of 1.48%. The ex-dividend date is Thursday, March 24th. This is a boost from Glanbia's previous dividend of GBX 0.12. The official announcement can be viewed at this link.
View Glanbia's dividend history

Is Glanbia a good dividend stock?

Glanbia pays an annual dividend of GBX 0.28 per share and currently has a dividend yield of 2.65%. The dividend payout ratio of Glanbia is 48.24%. This payout ratio is at a healthy, sustainable level, below 75%.
View Glanbia's dividend history.

Who are Glanbia's key executives?
Glanbia's management team includes the following people:
  • Ms. Siobhan Talbot B.Comm, FCA, Group MD & Exec. Director (Age 58, Pay $1.97M)
  • Mr. Mark A. Garvey, Group Fin. Director & Exec. Director (Age 58, Pay $1.08M)
  • Mr. Brian Phelan, Chief Exec. Officer of Glanbia Nutritionals (Age 55)
  • Mr. Hugh McGuire, Chief Exec. Officer of Glanbia Performance Nutrition (Age 51)
  • Mr. Liam Hennigan, Group Sec., Head of Investor Relations & Grp. Dir. of Strategic Planning and Investor Relations
  • Ms. Martha Kavanagh, Head of Corp. Communications
  • Mr. Tom Tench, Group Corp. Devel. Director (Age 51)
  • Mr. Michael Patten, Director of Group HR & Corp. Affairs (Age 60)
  • Mr. Jim Bergin, Chief Exec. of Glanbia Ingredients Ireland Limited (Age 59)
  • Mr. Colin Gordon BBS, MBS, FMII, Chief Exec. Officer of Consumer Products (Age 60)
What other stocks do shareholders of Glanbia own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Glanbia investors own include Reckitt Benckiser Group (RB), Kerry Group (KRYAY), Kimberly-Clark (KMB), Glanbia (GLAPY), Glanbia (GLAPF), Diageo (DEO), Dalata Hotel Group (DAL), Bank of Ireland Group (BIRG), Atalaya Mining (ATYM) and Amryt Pharma (AMYT).

What is Glanbia's stock symbol?

Glanbia trades on the London Stock Exchange (LON) under the ticker symbol "GLB."

How do I buy shares of Glanbia?

Shares of GLB and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Glanbia's stock price today?

One share of GLB stock can currently be purchased for approximately GBX 11.43.

How much money does Glanbia make?

Glanbia has a market capitalization of £31.65 million and generates £4.20 billion in revenue each year.

How many employees does Glanbia have?

Glanbia employs 8,071 workers across the globe.

What is Glanbia's official website?

The official website for Glanbia is www.glanbia.com.

How can I contact Glanbia?

Glanbia's mailing address is Glanbia House, KILKENNY,, Ireland. The company can be reached via phone at +353-56-7772200.

This page was last updated on 5/28/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.